Investors Buy Shares of Equifax (EFX) on Weakness

Investors bought shares of Equifax (NYSE:EFX) on weakness during trading on Monday. $42.17 million flowed into the stock on the tick-up and $19.12 million flowed out of the stock on the tick-down, for a money net flow of $23.05 million into the stock. Of all companies tracked, Equifax had the 22nd highest net in-flow for the day. Equifax traded down ($0.73) for the day and closed at $116.85

EFX has been the topic of a number of recent research reports. Zacks Investment Research lowered shares of Equifax from a “hold” rating to a “sell” rating in a research note on Tuesday, January 9th. Wells Fargo reiterated a “buy” rating and set a $132.00 price target (up from $127.00) on shares of Equifax in a research note on Monday, March 5th. William Blair reiterated an “outperform” rating on shares of Equifax in a research note on Thursday, March 1st. Morgan Stanley boosted their price target on shares of Equifax from $112.00 to $119.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 31st. Finally, Barclays downgraded Equifax from an “overweight” rating to an “equal weight” rating and boosted their price objective for the stock from $115.00 to $128.00 in a research report on Thursday, December 14th. Nine analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $128.21.

How to Become a New Pot Stock Millionaire

The stock has a market capitalization of $14,124.17, a P/E ratio of 19.57, a PEG ratio of 1.99 and a beta of 0.93. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.60 and a quick ratio of 0.60.

Equifax (NYSE:EFX) last announced its quarterly earnings data on Thursday, March 1st. The credit services provider reported $1.39 EPS for the quarter, topping the Zacks’ consensus estimate of $1.35 by $0.04. Equifax had a return on equity of 23.31% and a net margin of 17.47%. The business had revenue of $838.50 million during the quarter, compared to the consensus estimate of $825.70 million. During the same period in the previous year, the company posted $1.42 earnings per share. The business’s revenue for the quarter was up 4.7% on a year-over-year basis. research analysts anticipate that Equifax will post 5.92 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, March 30th. Investors of record on Monday, March 12th were issued a $0.39 dividend. This represents a $1.56 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date was Friday, March 9th. Equifax’s dividend payout ratio (DPR) is 26.13%.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Telemus Capital LLC acquired a new position in Equifax in the fourth quarter valued at approximately $859,000. Comgest Global Investors S.A.S. acquired a new position in Equifax in the fourth quarter valued at approximately $1,828,000. Northwestern Mutual Wealth Management Co. boosted its holdings in Equifax by 144.0% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,223 shares of the credit services provider’s stock valued at $262,000 after purchasing an additional 1,312 shares in the last quarter. Capital International Investors acquired a new position in Equifax in the third quarter valued at approximately $513,940,000. Finally, Capital Bank & Trust Co acquired a new position in Equifax in the third quarter valued at approximately $29,838,000. 93.41% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Investors Buy Shares of Equifax (EFX) on Weakness” was first reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3344055/investors-buy-shares-of-equifax-efx-on-weakness.html.

About Equifax

Equifax Inc provides information solutions and human resources business process outsourcing services for businesses, governments, and consumers. The company operates through four segments: U.S. Information Solutions (USIS), International, Workforce Solutions, and Global Consumer Solutions. The USIS segment offers consumer and commercial information services, such as credit information and credit scoring, credit modeling and portfolio analytics, locate, fraud detection and prevention, identity verification, and other consulting; mortgage loan origination information; financial marketing; and identity management services.

Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

$1.32 Billion in Sales Expected for Canadian Pacific Railway  This Quarter
$1.32 Billion in Sales Expected for Canadian Pacific Railway This Quarter
Somewhat Positive Media Coverage Somewhat Unlikely to Affect Whiting Petroleum  Stock Price
Somewhat Positive Media Coverage Somewhat Unlikely to Affect Whiting Petroleum Stock Price
PS Business Parks  Given News Sentiment Rating of 0.09
PS Business Parks Given News Sentiment Rating of 0.09
Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Fulton Financial  Share Price
Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Fulton Financial Share Price
AAON  Downgraded to “Sell” at BidaskClub
AAON Downgraded to “Sell” at BidaskClub
Applied DNA Sciences  Given a $5.00 Price Target by Maxim Group Analysts
Applied DNA Sciences Given a $5.00 Price Target by Maxim Group Analysts


Leave a Reply

© 2006-2018 Ticker Report. Google+.